Back

Fractalkine Inhibition in Acute Myocardial Infarction leads to reduced intramyocardial haemorrhage

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Myocardial infarction: new scientific insights Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Shu Loh

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Reward system activation improves recovery from acute myocardial infarction
Ms H. Haykin (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Locally increased dysferlin expression improves left-ventricular function by stabilizing membrane nanodomains of cardiomyocytes in the myocardial infarction border zone
Mr J. Wegener (Goettingen, DE)
Abstract Slides Video
Presentation thumbnail
Macrophage MST4 exacerbates cardiac microvascular ischaemia/reperfusion injury by phosphorylating ACLY
Mr A. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Clec4e deletion in cardiac resident cells leads to smaller infarct size and better cardiac remodeling following myocardial ischemia-reperfusion injury
Doctor M. Algoet (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Synthetic torpor confers cardioprotection against myocardial ischaemia/reperfusion injury in the rat
Mr M. Ali Khan (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial infarction: new scientific insights

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Inhibition of fractalkine signalling in patients with acute myocardial infarction - First results from the FRACTAL trial
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes
thumbnail
Congress Presentation
Early blood-derived predictors of final infarct size in patients with anterior STEMI and primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources